Short Courses for Medical Doctors

This session describes the management of patients admitted to critical care with Guillain-Barré Syndrome, motor neurone disease, myasthenia gravis, critical illness polyneuropathy, critical illness neuromyopathy and Parkinson's disease.

This session contains a link to the BJA Education article<br><br>The article will open in a new window/tab depending on your browser.<br><br>CPD credit can be claimed for the time spent reading the article.<br><br><i>Endocrine problems in the critically i

This session contains a link to the BJA Education article.<br><br>The article will open in a new window/tab depending on your browser.<br><br>CPD credit can be claimed for the time spent reading the article.<br><br><i>Endocrine problems in the critically

This session describes the diagnosis and management of patients with new or known HIV in critical care.

This session explores the rationale for critical care admission in the postoperative patient, how to identify patients likely to benefit from critical care, and the benefits of admission.

This session contains a link to the BJA Education article followed by a series of self assessment multiple choice questions.<br><br>The article will open in a new window or tab depending on your browser.<br><br> CPD credits are awarded by the RCoA for the

This session contains a link to the BJA Education article followed by a series of self assessment multiple choice questions.<br><br>The article will open in a new window or tab depending on your browser.<br><br> CPD credits are awarded by the RCoA for the

This session describes the role and implementation of critical care outreach services, as well as other relevant issues.

This session introduces critical care medicine, provides a structured approach to clinical management and introduces some commonly used terminology.

This session defines the mortality rate for patients admitted to ICUs in the UK and discusses important aspects of severity of illness scoring systems that are applied to this population. This session also looks at the longer-term non-mortality outcomes e